High Doses Biotin beyond Its Nutraceutical Prescription: Update Indications for Neurological Diseases

Authors

  • Marwan S.M. Al-Nimer Department of Pharmacology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq

DOI:

https://doi.org/10.37591/rrjom.v7i2.55

Abstract

Biotin or vitamin H is ubiquitous B-complex vitamin that plays as a co-factor in different metabolic process in the body. The usual recommended daily requirement is 30µg. Recent studies found biotin in high doses involved in the synthesis of myelin in patients with multiple sclerosis.  The Med Day Pharmaceuticals launched an oral formulation of biotin high dose (Cerenday 100 mg capsule) and recommended for multiple sclerosis. Previous studies demonstrated the effectiveness of biotin in other neurological diseases that suggesting biotin exerts pleotropic effects. Therefore, it is worth trying to highlight the importance of using this nutrient for neurological diseases as the safety testing did not explore any harmful effect of biotin.

Keywords: Biotin, progressive multiple sclerosis, pleotropic effect

Cite this Article
Marwan S.M. Al-Nimer. High doses
biotin beyond its nutraceutical
prescription: update indications for
neurological diseases. Research &
Reviews: Journal of Medicine. 2017;
7(2): 13–20p.

 

Downloads

Published

2017-12-22

Issue

Vol. 7 No. 2 (2017)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.